We also evaluated blood aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels to determine liver damage by biogenic amines in developmental NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.